Max Robotics — Global Service Robot Directory + US Certification

About

Nam Hoon Cho is a pioneering surgeon and clinical researcher whose work centers on the application of transoral robotic surgery (TORS) for advanced head and neck cancers, particularly oropharyngeal and laryngo-hypopharyngeal malignancies. His major contributions lie in demonstrating the feasibility and oncologic safety of robotic-assisted approaches for stage III-IV oropharyngeal squamous cell carcinoma, a field where open surgery often carries significant morbidity. Cho’s 2017 study on TORS-based therapy for advanced oropharyngeal cancer (36 citations) established a paradigm for combining minimally invasive resection with customized adjuvant therapy. He further advanced the field through landmark clinical trials integrating neoadjuvant chemotherapy with TORS for T3-T4 oropharyngeal (27 citations) and laryngo-hypopharyngeal cancers (26 citations), showing improved functional outcomes without compromising survival. Beyond head and neck oncology, Cho has contributed to urologic robotics, notably in a 2011 study (30 citations) clarifying the prognostic significance of perineural and lymphovascular invasion in robot-assisted radical prostatectomy. His work has been instrumental in expanding the indications for robotic surgery, offering patients with advanced disease less invasive treatment options while maintaining rigorous oncologic standards.